Literature DB >> 32562817

Blame the signaling: Role of cAMP for the resolution of inflammation.

Luciana P Tavares1, Graziele L Negreiros-Lima2, Kátia M Lima3, Patrícia M R E Silva4, Vanessa Pinho5, Mauro M Teixeira6, Lirlândia P Sousa7.   

Abstract

A complex intracellular signaling governs different cellular responses in inflammation. Extracellular stimuli are sensed, amplified, and transduced through a dynamic cellular network of messengers converting the first signal into a proper response: production of specific mediators, cell activation, survival, or death. Several overlapping pathways are coordinated to ensure specific and timely induction of inflammation to neutralize potential harms to the tissue. Ideally, the inflammatory response must be controlled and self-limited. Resolution of inflammation is an active process that culminates with termination of inflammation and restoration of tissue homeostasis. Comparably to the onset of inflammation, resolution responses are triggered by coordinated intracellular signaling pathways that transduce the message to the nucleus. However, the key messengers and pathways involved in signaling transduction for resolution are still poorly understood in comparison to the inflammatory network. cAMP has long been recognized as an inducer of anti-inflammatory responses and cAMP-dependent pathways have been extensively exploited pharmacologically to treat inflammatory diseases. Recently, cAMP has been pointed out as coordinator of key steps of resolution of inflammation. Here, we summarize the evidence for the role of cAMP at inducing important features of resolution of inflammation.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Phosphodiesterase 4; Pro-resolving mediators; Resolution pharmacology; cAMP

Mesh:

Substances:

Year:  2020        PMID: 32562817     DOI: 10.1016/j.phrs.2020.105030

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  10 in total

Review 1.  Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.

Authors:  Archana Shankar; Jaclyn W McAlees; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2022-08       Impact factor: 14.290

2.  Ablation of PDE4B protects from Pseudomonas aeruginosa-induced acute lung injury in mice by ameliorating the cytostorm and associated hypothermia.

Authors:  Lina Abou Saleh; Abigail Boyd; Ileana V Aragon; Anna Koloteva; Domenico Spadafora; Wadad Mneimneh; Robert A Barrington; Wito Richter
Journal:  FASEB J       Date:  2021-09       Impact factor: 5.834

Review 3.  CXCR4 as a novel target in immunology: moving away from typical antagonists.

Authors:  Birgit Caspar; Pietro Cocchiara; Armelle Melet; Kristof Van Emelen; Annegret Van der Aa; Graeme Milligan; Jean-Philippe Herbeuval
Journal:  Future Drug Discov       Date:  2022-07-19

4.  PGE2 inhibits neutrophil phagocytosis through the EP2R-cAMP-PTEN pathway.

Authors:  Zixuan Wang; Xinyuan Wei; Caili Ji; Wenhua Yu; Chuanwang Song; Caizhi Wang
Journal:  Immun Inflamm Dis       Date:  2022-07

5.  SETD4 in the Proliferation, Migration, Angiogenesis, Myogenic Differentiation and Genomic Methylation of Bone Marrow Mesenchymal Stem Cells.

Authors:  Xiaomin Liao; Caixia Wu; Zhongming Shao; Shuya Zhang; Yuan Zou; Keke Wang; Yanping Ha; Jingci Xing; Axiu Zheng; Zhihua Shen; Shaojiang Zheng; Junli Guo; Wei Jie
Journal:  Stem Cell Rev Rep       Date:  2021-01-27       Impact factor: 5.739

6.  Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.

Authors:  Bufu Tang; Jinyu Zhu; Baohui Zhang; Fazong Wu; Yajie Wang; Qiaoyou Weng; Shiji Fang; Liyun Zheng; Yang Yang; Rongfang Qiu; Minjiang Chen; Min Xu; Zhongwei Zhao; Jiansong Ji
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

Review 7.  Purinergic Signaling in the Regulation of Gout Flare and Resolution.

Authors:  Xiaoling Li; Jie Gao; Jinhui Tao
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

8.  Exploring the Muscle Metabolomics in the Mouse Model of Sepsis-Induced Acquired Weakness.

Authors:  Yikang Jiang; Qiang Wei; Wei Liu; Qiunan Chen; Xia Chen; Zhongzhen Yuan; Na Luo; Xi Chen; Chuanjiang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-16       Impact factor: 2.650

Review 9.  Th2A cells: The pathogenic players in allergic diseases.

Authors:  Ziyu Huang; Ming Chu; Xi Chen; Ziyuan Wang; Lin Jiang; Yinchao Ma; Yuedan Wang
Journal:  Front Immunol       Date:  2022-08-08       Impact factor: 8.786

Review 10.  Emerging Role of cAMP/AMPK Signaling.

Authors:  Muhammad Aslam; Yury Ladilov
Journal:  Cells       Date:  2022-01-17       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.